系统性硬化症

系统性硬化症肺部高分辨率CT表现

HRCT of the lung in systemic sclerosis

目的分析系统性硬化症（SSc）的临床表现，探讨其免疫学改变的意义。

Objective To study clinical manifestation and immunological abnormality of the patients who suffered from systemic sclerosis ( SSc ) .

日本系统性硬化症患者中的抗DNA拓扑异构酶Ⅱα自身抗体

Anti - DNA topoisomerase ⅱ α autoantibodies in Japanese patients with systemic sclerosis

抗Ku抗体对系统性硬化症并多发性肌炎的特异性为99.4%。

The specificity of anti Ku antibodies for diagnosis of SSc PM was 99.4 % .

结论抗Ku抗体是系统性硬化症并多发性肌炎重叠结缔组织病的相对特异性抗体。

Conclusion The anti Ku antibody is relatively specific for systemic sclerosis polymyositis overlap connective tissue disease .

目的：观察依地酸钙钠（EDTA）治疗系统性硬化症（SSc）的疗效及安全性。

Objective : To evaluate the efficacy and safety of calcium disodium ethylenediamine tetracetic acid ( EDTA ) in the management of systemic sclerosis ( SSc ) .

目的通过检测系统性硬化症（PSS）患者的肾上腺轴激素和分析其临床表现，探讨PSS与肾阳虚的关系。

Objective To discuss the relation between systemic sclerosis ( PSS ) and deficiency of kidney-Yang by checking the patients'hormones of adrenal gland axis and analyzing their clinical symptoms .

目的：观察重组干扰素γ对系统性硬化症（SSc）的疗效和安全性。

Objective : To survey the therapeutic effectiveness and safety rate of recombinant interferon-gamma ( IFN - γ) in the treatment of systemic sclerosis ( SSc ) .

结果438份CTD患者血清中12例Ku抗体阳性，其中系统性硬化症多发性肌炎重叠结缔组织病（SScPM）占9例。

Results Among the 438 CTD patients , 12 had positive Ku Ab , and among the 15 systemic sclerosis polymyositis ( SSc PM ) overlap syndrome , 9 had positive Ku Ab.

为了解系统性硬化症（SSc）肺部损害与肺部肿瘤的关系，我们检查了226例SSc患者的X线胸片、肺断层CT及肺功能。

To investigate the relationship between the pulmonary lesions and the pulmonary malignancies in systemic sclerosis ( SSc ) chest film of X-ray , pulmonary CT and pulmonary function of 226 patients with SSc were tested .

抗Scl-70抗体则特异性地见于进行性系统性硬化症（PSS），阳性率为33.34±27.2%；

That anti scl-70 antibody was specially seen in progressive systemic sclerosis ( PSS ) and its positive rate was 33 . 3 ± 27 . 2 % ;

血浆置换治疗系统性硬化症回顾分析

Retrospective analysis of the effectiveness of plasma exchange on systemic sclerosis

类风湿性关节炎和进行性系统性硬化症患者的肺功能改变

Pulmonary Functions in Patients with Rheumatoid Arthritis and Progressive Systemic Sclerosis

系统性硬化症肺部病变的临床特征及病理特点

Clinicopathological Studies of Pulmonary Involvement of Patients with Systemic Sclerosis

系统性硬化症病人桡动脉采血技巧探讨

Probe into skills of radial artery blood collection for systemic sclerosis patients

慢性进行性感觉性共济失调神经病变与自限性系统性硬化症的关系

Chronic progressive sensory ataxic neuropathy associated with limited systemic sclerosis

系统性硬化症25例临床和免疫学分析

Clinical and immunological features of 25 patients with systemic sclerosis

系统性硬化症肺损害52例临床分析

Clinical analyses of the lung diseases in 52 patients with systemic sclerosis

重组干扰素γ治疗系统性硬化症15例

Treatment of 15 Cases of Systemic Sclerosis with Recombinant Interferon-gamma

进行性系统性硬化症肺功能测定的意义

The value of pulmonary function measurements in progressive systemic Sclerosis

甲襞微循环在系统性硬化症中的临床意义及特点

Clinical significance and features of nail fold microcirculation in systemic sclerosis patients

系统性硬化症硬皮病性肾病急性肾衰竭

Systemic sclerosis , scleroderma kidney disease , acute renal failure

系统性硬化症的肾脏损害

Clinicopathological studies of renal involvement in patients with systemic sclerosis

系统性硬化症致肺功能损害的探讨

Study of pulmonary function injury caused by system scleroderma

进行性系统性硬化症的皮肤外表现

The extra-skin manifestations of progressive systemic sclerosis

进行性系统性硬化症患者血清一氧化氮含量和食管动力变化特征的研究

Study on Serum Concentration of Nitric Oxide and Esophageal Motility Changes in Patients with Progressive Systemic Sclerosis

系统性硬化症1例

Systemic sclerosis : one case

报告指出，锡伯族的系统性硬化症患者比非锡伯族系统性硬化症患者在腹泻和更高的中位全球症状评分上具有更高的流行率。

Systemic sclerosis patients with SIBO had a higher prevalence of diarrhea and a higher median global symptom score than did systemic sclerosis patients without SIBO , the report indicates .

1例糖尿病、1例尿酸性肾炎、1例系统性进行性硬化症，双肾影稍增大或大小正常。

The images of double kidneys were slightly ampliative or normal in 1 ease of patient with diabetes , 1 with uratic nephritis as well as 1 with progressive systemic sclerosis .

系统性红斑狼疮及系统性硬化症的血液学异常分析

The hematology abnormality in systemic lupus erythematosus and progressive systemic sclerosis